Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Chubb
Moodys
Mallinckrodt
Boehringer Ingelheim

Generated: May 21, 2019

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: zolpidem tartrate

« Back to Dashboard

zolpidem tartrate Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Mylan Pharms Inc zolpidem tartrate 078016 5MG TABLET;ORAL
Synthon Pharms zolpidem tartrate 077540 5MG TABLET;ORAL
Mylan Pharms Inc zolpidem tartrate 078016 10MG TABLET;ORAL
Synthon Pharms zolpidem tartrate 077540 10MG TABLET;ORAL
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Chubb
McKinsey
Medtronic
Boehringer Ingelheim
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.